The effects of di(2-ethylhexyl)phthalate on rat liver in relation to selenium status

International Journal of Experimental Pathology

Volumn 95, Issue 1, 2014, Pages 64-77

  Erkekoglu, Pinar ^a   Zeybek, Naciye D ^a   Giray, Belma K ^a   Rachidi, Walid ^b   Kizilgün, Murat ^c   Hininger Favier, Isabelle ^d   Favier, Alain ^b   Asan, Esin ^a   Hincal, Filiz ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b CEA GRENOBLE   (France)

^c MINISTRY OF HEALTH   (Turkey)

^d Domaine Universitaire   (France)

Author keywords

Antioxidant enzymes; Di(ethylhexyl)phthalate; Liver; Oxidative stress; Selenium deficiency; Selenium supplementation

Indexed keywords

AMINOTRANSFERASE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE TRANSFERASE; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; SELENIUM; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL DISRUPTION; CELL PROLIFERATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FEEDING; HISTOPATHOLOGY; IMMUNOREACTIVITY; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LIPID PEROXIDATION; LIVER TOXICITY; MALE; NONHUMAN; NUTRITIONAL STATUS; OXIDATIVE STRESS; PEROXISOME; PRIORITY JOURNAL; RAT; SELENIUM DEFICIENCY; TREATMENT DURATION;

ANTIOXIDANT ENZYMES; DI(ETHYLHEXYL)PHTHALATE; LIVER; OXIDATIVE STRESS; SELENIUM DEFICIENCY; SELENIUM SUPPLEMENTATION;

ANIMALS; APOPTOSIS; CATALASE; DIETHYLHEXYL PHTHALATE; LIPID PEROXIDATION; LIVER; MALE; MODELS, ANIMAL; OXIDATIVE STRESS; PEROXISOMES; RATS; RATS, SPRAGUE-DAWLEY; SELENIUM;

EID: 84893007105     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/iep.12059     Document Type: Article

References (79)

1. Aebi H. (1974) Catalase. In: Methods of Enzymatic Analysis, 2nd edn (ed. HU Bergmeyer), New York: Academic press 3: 673.
2. Akerboom T.P. & Sies H. (1981) Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Meth. Enzymol. 77, 373-382.
3. Akingbemi B.T., Ge R., Klinefelter G.R., Zikrin B.R., Hardy M.P. (2004) Phthalate induced Leydig cell hyperplasia is associated with multiple endocrine disturbances. Proc. Natl Acad. Sci. USA 101, 775-780.
4. Arnér E.S., Zhong L., Holmgren A. (1999) Preparation and assay of mammalian thioredoxin and thioredoxin reductase. Methods Enzymol. 300, 226-239.
5. Arnér E.S. (2009) Focus on mammalian thioredoxin reductases-important selenoproteins with versatile functions. Biochim. Biophys. Acta 1790, 495-526.
6. Arnér E.S. & Holmgren A. (2006) The thioredoxin system in cancer. Semin. Cancer Biol. 16, 420-426.
7. Botelho G.G., Bufalo A.C., Boareto A.C. et al. (2009) Vitamin C and resveratrol supplementation to rat dams treated with di(2-ethylhexyl)phthalate: impact on reproductive and oxidative stress end points in male offspring. Arch. Environ. Contam. Toxicol. 57, 785-793.
8. Clark L.C., Cantor K.P., Allaway W.H. (1991) Selenium in forage crops and cancer mortality in US counties. Arch. Environ. Health 46, 37-42.
9. Conway J.G., Cattley R.C., Popp J.A., Butterworth B.E. (1989) Possible mechanisms in hepatocarcinogenesis by the peroxisome proliferator di(2-ethylhexyl)phthalate. Drug Metab. Rev. 21, 65-102.
10. Costantini S., Lepore M.G., Castello G., Colonna G. (2011) Has selenium a chemopreventive effect on hepatocellular carcinoma? Mini. Rev. Med. Chem. 1, 599-610.
11. Darvesh A.S. & Bishayee A. (2010) Selenium in the prevention and treatment of hepatocellular carcinoma. Anticancer Agents Med. Chem. 10, 338-345.
12. 2 in primary cultured pig thyrocytes. Eur. J. Endocrinol. 50, 841-849.
13. El-Shinnawy N.A. (2013) The therapeutic applications of celery oil seed extract on the plasticizer di(2-ethylhexyl) phthalate toxicity. Toxicol. Ind. Health. doi: 10.1177/0748233713475515 (Ahead of print).
14. Erkekoglu P., Rachidi W., De Rosa V., Giray B., Favier A., Hincal F. (2010a) Protective effect of selenium supplementation on the genotoxicity of di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate treatment in LNCaP cells. Free Radic. Biol. Med. 49, 559-566.
15. Erkekoglu P., Rachidi W., Yuzugullu O.G. et al. (2010b) Evaluation of cytotoxicity and oxidative DNA damaging effects of di(2-ethylhexyl)-phthalate (DEHP) and mono(2-ethylhexyl)-phthalate (MEHP) on MA-10 Leydig cells and protection by selenium. Toxicol. Appl. Pharmacol. 248, 52-62.
16. Erkekoglu P., Zeybek N.D., Giray B., Asan E., Arnaud J., Hincal F. (2011a) Reproductive toxicity of di(2-ethylhexyl) phthalate in selenium-supplemented and selenium-deficient rats. Drug Chem. Toxicol. 34, 379-389.
17. Erkekoglu P., Giray B., Rachidi W. et al. (2011b) Effects of di(2-ethylhexyl)phthalate on testicular oxidant/antioxidant status in selenium-deficient and selenium-supplemented rats. Environ. Toxicol. doi: 10.1002/tox.20776.
18. Erkekoglu P., Giray B.K., Kizilgün M. et al. (2012a) Di(2-ethylhexyl)phthalate-induced renal oxidative stress in rats and protective effect of selenium. Toxicol. Mech. Methods 22, 415-423.
19. Erkekoglu P., Giray B.K., Kizilgün M. et al. (2012b) Thyroidal effects of di-(2-Ethylhexyl) phthalate in rats at different selenium status. J. Environ. Pathol. Toxicol. Oncol. 31, 143-153.
20. Erkhembayar S., Mollbrink A., Eriksson L.C. (2012) The effect of sodium selenite on liver growth and thioredoxin reductase expression in regenerative and neoplastic liver cell proliferation. Biochem. Pharmacol. 83, 687-693.
21. Flohé L. & Günzler W.A. (1984) Assays of glutathione peroxidase. Meth. Enzymol. 105, 114-121.
22. Fromme H., Gruber L., Schlummer M. et al. (2007) Intake of phthalates and di(2-ethylhexyl)adipate: results of the Integrated Exposure Assessment Survey based on duplicate diet samples and biomonitoring data. Environ. Int. 33, 1012-1020.
23. Ganther D.E. (1999) Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 20, 1657-1666.
24. Gayathri N.S., Dhanya C.R., Indu A.R., Kurup P.A. (2004) Changes in some hormones by low doses of di (2-ethyl hexyl) phthalate (DEHP), a commonly used plasticizer in PVC blood storage bags & medical tubing. Indian J. Med. Res. 119, 139-144.
25. Gazouli M., Yao Z.X., Boujrad N., Corton J.C., Culty M., Papadopoulos V. (2002) Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: role of the peroxisome proliferator-activator receptor alpha. Endocrinology 143, 2571-2583.
26. Giray B., Riondel J., Richard M.J., Favier A., Hincal F. (2004) Oxidant/antioxidant status in relation to thyroid hormone metabolism in selenium- and/or iodine-deficient rats. J. Trace Elem. Exp. Med. 17, 109-121.
27. Gromer S., Eubel J.K., Lee B.L., Jacob J. (2005) Human selenoproteins at a glance. Cell. Mol. Life Sci. 62, 2414-2437.
28. Habig W.H., Pabst M.J., Jakoby W.B. (1974) Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249, 7130-7139.
29. Hafeman D.G., Sunde R.A., Hoekstra W.G. (1974) Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J. Nutr. 104, 580-587.
30. Hasmall S.C., James N.H., Macdonald N., Soames A.R., Roberts R.A. (2000) Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression. Arch. Toxicol. 74, 85-91.
31. Hernández-Díaz S., Mitchell A.A., Kelley K.E., Calafat A.M., Hauser R. (2009) Medications as a potential source of exposure to phthalates in the U.S. population. Environ. Health Perspect. 117, 185-189.
32. Irmak M.B., Ince G., Ozturk M., Cetin-Atalay R. (2003) Acquired tolerance of hepatocellular carcinoma cells to selenium deficiency: a selective survival mechanism? Cancer Res. 63, 6707-6715.
33. Isenberg J.S., Kolaja K.L., Ayoubi S.A., Watkins J.B. 3rd, Klaunig J.E. (1997) Inhibition of WY-14, 643 induced hepatic lesion growth in mice by rotenone. Carcinogenesis 18, 1511-1519.
34. Jablonska E., Gromadzinska J., Reszka E. et al. (2009) Association between GPx1 Pro198Leu polymorphism, GPx1 activity and plasma selenium concentration in humans. Eur. J. Nutr. 48, 383-386.
35. James N.H., Soames A.R., Roberts R.A. (1998) Suppression of hepatocyte apoptosis and induction of DNA synthesis by the rat and mouse hepatocarcinogen diethylhexylphlathate (DEHP) and the mouse hepatocarcinogen 1, 4-dichlorobenzene (DCB). Arch. Toxicol. 72, 784-790.
36. Klaunig J.E., Babich M.A., Baetcke K.P. et al. (2003) PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit. Rev. Toxicol. 33, 655-780.
37. Kluwe W.M., Huff J.E., Matthews H.B., Irwin R., Haseman J.K. (1985) Comparative chronic toxicities and carcinogenic potentials of 2-ethylhexyl-containing compounds in rats and mice. Carcinogenesis 6, 1577-1583.
38. Latini G. (2005) Monitoring phthalate exposure in humans. Clin. Chim. Acta 361, 20-29.
39. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. (1951) Protein measurement with Folin phenol reagent. J. Biol. Chem. 193, 265-275.
40. Maiorino M., Gregolin C., Ursini F. (1990) Phospholipid hydroperoxide glutathione peroxidase. Meth. Enzymol. 186, 448-457.
41. Marklund S., Marklund G. (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47, 469-474.
42. Medina J. & Moreno-Otero R. (2005) Pathophysiological basis for antioxidant therapy in chronic liver disease. Drugs 65, 2445-2461.
43. Melnick R.L. (2001) Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)? Environ. Health Perspect. 109, 437-442.
44. Moody D.E. & Reddy J.K. (1978) The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14, 643) on hepatic peroxisomes and peroxisome-associated enzymes. Am. J. Pathol. 90, 435-446.
45. Moody D.E., Reddy J.K., Lake B.G., Popp J.A., Reese D.H. (1991) Peroxisome proliferation and nongenotoxic carcinogenesis: commentary on a symposium. Fundam. Appl. Toxicol. 16, 233-248.
46. Mushtaq M., Srivastava S.P., Seth P.K. (1980) Effect of di-2-ethylhexyl phthalate (DEHP)on glycogen metabolism in rat liver. Toxicology 16, 153-161.
47. Mustacich D. & Powis G. (2000) Thioredoxin reductase. Biochem. J. 346, 1-8.
48. National Research Council (NRC) (1995) Nutrient Requirements of Laboratory Animals. 4th revised edn. Washington, DC: National Academy Press.
49. Nose K. (2000) Role of reactive oxygen species in the regulation of physiological functions. Biol. Pharm. Bull. 23, 897-903.
50. Oberley T.D., Zhong W., Szweda L.I., Oberley L.W. (2000) Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium. Prostate 44, 144-155.
51. O'Brien M.L., Spear B.T., Glauert H.P. (2005) Role of oxidative stress in peroxisome proliferator-mediated carcinogenesis. Crit. Rev. Toxicol. 35, 61-88.
52. O'Brien M.L., Twaroski T.P., Cunningham M.L., Glauert H.P. & Spear B.T. (2001) Effects of peroxisome proliferators on antioxidant enzymes and antioxidant vitamins in rats and hamsters. Toxicol Sci. 60, 271-278.
53. Olsson U., Garberg P., Lundgren B. et al. (1992) The involvement of selenium in peroxisome proliferation caused by dietary administration of clofibrate to rats. Chem. Biol. Interact. 5, 49-67.
54. Reddy J.K. & Rao M.S. (1989) Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis. Mutat. Res. 214, 63-68.
55. Reddy J.K. & Rao M.S. (1992) Peroxisome proliferation and hepatocarcinogenesis. IARC Sci. Publ. 116, 225-235.
56. Richard M.J., Portal B., Meo J., Coudray C., Hadjian A., Favier A. (1992) Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin. Chem. 38, 704-709.
57. Roberts R.A., James N.H., Hasmall S.C. et al. (2000) Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARalpha. Toxicol. Lett. 112-113, 49-57.
58. Rohr-Udilova N., Sieghart W., Eferl R. et al. (2012) Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma. Hepatology 55, 1112-1121.
59. Rose M.L., Rusyn I., Bojes H.K., Belyea J., Cattley R.C., Thurman R.G. (2000) Role of Kupffer cells and oxidants in signaling peroxisome proliferator induced hepatocyte proliferation. Mutat. Res. 448, 179-192.
60. Rusyn I., Rose M.L., Bojes H.K., Thurman R.G. (2000) Novel role of oxidants in the molecular mechanism of action of peroxisome proliferators. Antioxid. Redox Signal. 2, 607-621.
61. Rusyn I., Kadiiska M.B., Dikalova A. et al. (2001) Phthalates rapidly increase production of reactive oxygen species in vivo: role of Kupffer cells. Mol. Pharmacol. 59, 744-750.
62. Rusyn I., Peters J.M., Cunningham M.L. (2006) Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver. Crit. Rev. Toxicol. 36, 459-479.
63. Saedi M.S., Smith C.G., Frampton J., Chambers I., Harrison P.R., Sunde R.A. (1988) Effect of selenium status on mRNA levels for glutathione peroxidase in rat liver. Biochem. Biophys. Res. Commun. 153, 855-861.
64. Sasaki Y. (2006) Does oxidative stress participate in the development of hepatocellular carcinoma? J. Gastroenterol. 41, 1135-1148.
65. Seo K.W., Kim K.B., Kim Y.J., Choi J.Y., Lee K.T., Choi K.S. (2004) Comparison of oxidative stress and changes of xenobiotic metabolizing enzymes induced by phthalates in rats. Food Chem. Toxicol. 42, 107-114.
66. Steinbrenner H. & Sies H. (2009) Protection against reactive oxygen species by selenoproteins. Biochim. Biophys. Acta 1790, 1478-1485.
67. Sundae R.A. (2003) Chapter 8. Regulation of selenoprotein expression. In: Selenium: Its Molecular Biology and Role in Human Health, (ed. Hatfield D), pp. 81-98. Massachusetts: Kluwer Academic Publishers.
68. Turan B., Acan N.L., Ulusu N.N., Tezcan E.F. (2001) A comparative study on effect of dietary selenium and vitamin E on some antioxidant enzyme activities of liver and brain tissues. Biol. Trace Elem. Res. 81, 141-152.
69. Urig S. & Becker K. (2006) On the potential of thioredoxin reductase inhibitors for cancer therapy. Semin. Cancer Biol. 16, 452-465.
70. Weitzel F., Ursini F., Wendel A. (1990) Phospholipid hydroperoxide glutathione peroxidase in various mouse organs during selenium deficiency and repletion. Biochim. Biophys. Acta 1036, 88-94.
71. Whanger P.D. (2004) Selenium and its relationship to cancer: an update. Br. J. Nutr. 91, 11-28.
72. Willhite C.C. (2001) Weight-of-evidence versus strength-of-evidence in toxicologic hazard identification: di(2-ethylhexyl)phthalate (DEHP). Toxicology 160, 219-226.
73. Wormuth M., Scheringer M., Vollenweider M., Hungerbühler K. (2006) What are the sources of exposure to eight frequently used phthalic acid esters in Europeans? Risk Anal. 26, 803-824.
74. Yeldandi A.V., Rao M.S., Reddy J.K. (2000) Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat. Res. 448, 159-177.
75. Yoo M.H., Carlson B.A., Tsuji P., Irons R., Gladyshev V.N., Hatfield D.L. (2010) Alteration of thioredoxin reductase 1 levels in elucidating cancer etiology. Methods Enzymol. 474, 255-275.
76. Youssef J.A., Bouziane M., Badr M.Z. (2003) Age-dependent effects of nongenotoxic hepatocarcinogens on liver apoptosis in vivo. Mech. Ageing Dev. 124, 333-340.
77. Yu M.W., Horng I.S., Hsu K.H., Chiang Y.C., Liaw Y.F., Chen C.J. (1999) Plasma selenium levels and risk of hepatocellular carcinoma among men wit chronic hepatitis virus infection. Am. J. Epidemiol. 150, 367-374.
78. Zhu H., Jia Z., Misra H., Li Y.R. (2012) Oxidative stress and redox signaling mechanisms of alcoholic liver disease: updated experimental and clinical evidence. J. Dig. Dis. 13, 133-142.
79. Zwolak I. & Zaporowska H. (2012) Selenium interactions and toxicity: a review. Selenium interactions and toxicity. Cell Biol. Toxicol. 28, 31-46.